Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONANTI: Serum Level Monitoring of Anti-Dementia Drugs
NCT04117178Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of donepezil and memantine in Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) (2 arms), sponsored by Zealand University Hospital. Primary endpoints: Mini Mental State Examination at 1 year, Adenbrooke's Cognitive Examination at 1 year and 2 more. Started Feb 2020; status: completed.
02
Drugs
donepezilmemantine
03
Conditions
Alzheimer's disease (AD)dementia with Lewy bodies (DLB)Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT04117178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117178.